Home

Sujal Shah

CIK 1588861 · Chief Executive Officer · last filed 2026-06-11

Sujal Shah is a Chief Executive Officer who has filed 38 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for TVRD, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$2.6M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

38

Lifetime Open-Market Net

-$2.62M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TVRD Director — $2.44 — $0 2 2026-06-11
CymaBay Therapeutics, Inc. (CBAY) Delisted Chief Executive Officer 0 $32.48 $0 -$2.62M 30 2024-03-22

Recent Filings

38 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-11 TVRD Grant (A) — $0 EDGAR
2025-04-21 TVRD Grant (A) — $0 EDGAR
2025-04-17 — Grant (A) — $0
2024-03-22 CymaBay Therapeutics, Inc. (CBAY) Delisted Disp (D) −406,670 $0 EDGAR
2024-03-15 CymaBay Therapeutics, Inc. (CBAY) Delisted Exer (M) +139,119 $656.0K EDGAR
2024-01-26 CymaBay Therapeutics, Inc. (CBAY) Delisted Grant (A) +96,250 $0 EDGAR
2023-12-11 — Notice (144) −64,865 -$1.30M EDGAR
2023-12-11 CymaBay Therapeutics, Inc. (CBAY) Delisted Mixed — -$972.8K EDGAR
2023-11-14 CymaBay Therapeutics, Inc. (CBAY) Delisted Mixed — -$706.3K EDGAR
2023-11-13 — Notice (144) −64,863 -$1.03M EDGAR
Showing 1–10 of 38
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.